Other promising targets for AML CAR‐T cell development include Lewis Y (LeY), FLT3, CLL1, CD44v6, Folate Receptor β (FRβ), CD38, and CD7.63, 73, 74. Here, CLEC12A is linked to acute myeloid leukemia.